연구성과로 돌아가기

2022 연구자 정보 (96 / 1074)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Suzuki, Fumitaka
(Suzuki, F)
Toranomon Hosp Kajigaya, Dept Hepatol, Kanagawa, Japan

[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Suzuki, Yoshiyuki
(Suzuki, Y)
Toranomon Hosp Kajigaya, Dept Hepatol, Tokyo, Japan

[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Sypsa, Vana
(Sypsa, V)
Natl & Kapodistrian Univ Athens, Dept Hyg Epidmiol & Med Stat, Med Sch, Athens, Greece
Natl & Kapodistrian Univ Athens, Dept Hyg Epidemiol & Med Stat, Med Sch, Athens, Greece
A-5082-2008
SYPSA, VANA
0000-0002-9430-7614
SYPSA, VANA
[JCR상위 3.8] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
[JCR상위 8.1] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY gepapath@med.uoa.gr;pindra@empal.com;
pindra@empal.com;gepapath@med.uoa.gr;
Tanaka, Yasuhito
(Tanaka, Y)
Nagoya City Univ Grad Sch Med Sci, Dept Virol, Liver Unit, Nagoya, Japan
Kumamoto Univ, Fac Life Sci, Dept Gastroenterol & Hepatol, Kumamoto, Japan
GNW-5820-2022
Tanaka, Yasuhito
0000-0002-2473-6966
Tanaka, Yasuhito
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Tao, Yu
(Tao, Y)
GSK, R&D Projects Clin Platforms & Sci, Collegeville, PA USA F-7296-2017
Tao, Yu

[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Theodore, Dickens
(Theodore, D)
GSK, Hepatol GI Clin Sci, Stevenage, Herts, England

[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Viacheslav, Morozov
(Viacheslav, M)
Hepatol LLC, Samara, Russia

[JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY frida.abramov@gilead.com;
Xie, Qing
(Xie, Q)
Shanghai Jiaotong Univ Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China
0000-0002-2582-8803
Xie, Qing
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Xie, Wen
(Xie, W)
Capital Med Univ, Beijing Ditan Hosp, Ctr Liver Dis, Beijing, Peoples R China

[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
Yang, M.
(Yang, M)
Gachon Univ, Gil Med Ctr, Internal Med, Incheon, South Korea
SMG SNU Boramae Hosp, Internal Med, Seoul, South Korea


[JCR상위 3.8] Accuracy Validation of Cough Counting AI Algorithm Using a Smartphone App in Patients with Asthma Exacerbation SCIE 3.8 CRITICAL CARE MEDICINE;RESPIRATORY SYSTEM sangminlee77@naver.com;
Yim, Hyung Joon
(Yim, HJ)
Korea Univ Ansan Hosp, Dept Internal Med, Ansan, South Korea
Korea Univ, Coll Med, Dept Internal Med, Ansan Hosp, Seoul, South Korea


[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy
[JCR상위 23.2] Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY
CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY
mfyuen@hku.hk;
limys@amc.seoul.kr;
Yoon, Eileen L.
(Yoon, EL)
Inje Univ, Sanggye Paik Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
Hanyang Univ, Hanyang Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
Inje Univ, Sanggye Paik Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
Hanyang Univ, Hanyang Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea


[JCR상위 3.8] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
[JCR상위 8.1] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY gepapath@med.uoa.gr;pindra@empal.com;
pindra@empal.com;gepapath@med.uoa.gr;
Yoon, Jun Sik
(Yoon, JS)
Inje Univ, Busan Paik Hosp, Coll Med, Busan, South Korea
Inje Univ, Busan Paik Hosp, Dept Internal Med, Coll Med, Busan, South Korea


[JCR상위 3.8] Noninvasive prediction of hepatocellular carcinoma development after oral antiviral therapy in patients with chronic hepatitis C: a multicenter study
[JCR상위 8.1] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY psyoung0419@gmail.com;
pindra@empal.com;gepapath@med.uoa.gr;
Yoon, Jung-Hwan
(Yoon, JH)
Seoul Natl Univ Hosp, Seoul Natl Univ Coll Med, Liver Res Inst, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ, Liver Res Inst, Dept Internal Med, Coll Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
J-5563-2012
Yoon, Jung

[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy
[JCR상위 3.8] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
[JCR상위 8.1] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY mfyuen@hku.hk;
gepapath@med.uoa.gr;pindra@empal.com;
pindra@empal.com;gepapath@med.uoa.gr;
Yoon, Ki Tae
(Yoon, KT)
Pusan Natl Univ Yangsan Hosp, Internal Med, Pusan, South Korea

[JCR상위 3.8] Diagnostic efficacy of Mac-2 binding protein glycosylation isomer for predicting liver fibrosis in patients with metabolic associated fatty liver disease SCIE 3.8 GASTROENTEROLOGY & HEPATOLOGY gongori1004@gmail.com;
페이지 이동: